Clinical Trials Directory

Trials / Completed

CompletedNCT02504450

Outcomes of Antipsychotic Medication Used in the Emergency Department

Outcomes of Antipsychotic Medication Use in the Emergency Department: A Retrospective Comparison Study

Status
Completed
Phase
Study type
Observational
Enrollment
93 (actual)
Sponsor
Wake Forest University Health Sciences · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

To review records of patients treated with antipsychotics (including Adasuve, Geodon, Haldol) in order to evaluate outcomes.

Detailed description

A retrospective chart review will be performed for all patients presenting to the ED with agitation and subsequently given antipsychotic therapy for treatment. Identification of patients will be through chart review of patients presenting with agitation. Data to be recorded include patient age, gender, medical history, time of presentation, time of treatment, co morbidities, use of restraint, time to disposition and patient outcome. Inclusion criteria include all patients over age 18 presenting to the ED with agitation and treated with antipsychotics. No patients will be knowingly excluded from analysis. We will compare resulting outcomes of patients treated for agitation to see if Adasuve is superior to other commonly prescribed antipsychotics through its rate of discharge home and overall time in the emergency department.

Conditions

Interventions

TypeNameDescription
DRUGAdasuveInhaled medication to treat acute agitation in the emergency department
DRUGAlternative medicationsMedication given to treat acute agitation in the emergency department

Timeline

Start date
2015-04-01
Primary completion
2016-03-01
Completion
2016-03-01
First posted
2015-07-22
Last updated
2024-10-04

Source: ClinicalTrials.gov record NCT02504450. Inclusion in this directory is not an endorsement.